Who can expect to get the COVID-19 antiviral pill in B.C., and how many will be available?
There's another tool in the fight against COVID-19 and B.C.'s top doctor said it will help prevent more serious illness if it's given to people early on.
Health Canada authorized the use of Pfizer's COVID-19 antiviral treatment Paxlovid Monday, and it's the first oral and at-home prescription medication to be cleared for use in the country.
In a news conference Tuesday, Dr. Bonnie Henry said the antiviral treatment is designed specifically for individuals at the highest risk of developing more severe illness and ending up in hospital.
"It includes those people in our community who are over age 70, clinically extremely vulnerable, immune compromised and for younger people who have additional medical conditions and don’t have the protection of vaccines."
Henry said B.C. can expect a limited supply of 4,000 treatment doses within the next few weeks.
The prescription-only medication must be started within five days of the onset of symptoms.
Henry added that the province is working with its clinical care advisory team to distribute the treatment where it can be the most effective.
"This is very good news. It's not going to change the trajectory of our pandemic right now but it's another tool to help those people who are more at-risk of ending up in hospital," she said.
University of British Columbia associate professor and drug safety researcher Mahyar Etminan said the treatment should not be viewed as a magic bullet.
"We don’t really have any data on children or healthy adults," he said. "So primarily, it was studied in adults who had COVID symptoms and had one other medical condition."
Etminan said the efficacy numbers being shared by the company for the treatment also need to be put in perspective.
"Unfortunately, the way they presented the data is this relative risk reduction metric, which tends to sort of overestimate the efficacy," he said, and noted Pfizer has reported an 88 per cent reduction of either hospitalization or death relative to the placebo group.
"In absolute numbers, it’s about a six per cent benefit...if 16 such participants took the drugs, one would benefit."
Etminan said roughly a thousand adults were part of the Pfizer study that received the antiviral combination, which helps prevent the replication of COVID in the body. He said a similar number were given a placebo.
"It’s also important to know that the data we have is data provided by the company," he said. "We still don’t have any peer-reviewed data from this study."
Etminan said based on the available data, "it seems like it should really be intended for adults who are at a high-risk of morbidity or dying from COVID."
"It comes down to risk versus benefits," he said. "It seems from the data we have that that sort of demographic would, right now at least, benefit the most from this drug."
Two additional vaccines, Medicago and Novavax, continue to be under review by Health Canada.
"We were hoping (Novavax) would be approved sometime in January, but it looks like it's more likely to be in February and Medicago may be as early as the end of January or February," Henry said.
"So I think that's important for those people who have made that determination that the mRNA vaccines that we have, and are holding out for something else. It's not going to be available to help you through this wave. But it is an additional option that will be coming, we hope, in the near future."
CTVNews.ca Top Stories
Western University researchers unlock potential 'cure' for ALS
New research out of London, Ont.’s Western University is shedding light on a potential cure for ALS, in which the targeting of the interaction between two proteins can halt or fully reverse the disease’s progression.
What Michael Cohen said on the stand in Trump hush money case
The star prosecution witness in Donald Trump's hush money trial took the stand Monday with testimony that could help shape the outcome of the first criminal case against an American president.
Collapsed Baltimore bridge span comes down with a boom after crews set off chain of explosives
Crews conducted a controlled demolition Monday to break down the largest remaining span of the collapsed Francis Scott Key Bridge in Baltimore.
Police release 3D images of young child found in an Ontario river two years ago
Police have released a three-dimensional image of a young child whose remains were discovered in the Grand River in Dunnville, Ont. almost two years ago.
Kamala Harris drops F-bomb during White House live-stream
U.S. Vice-President Kamala Harris used a profanity on Monday while offering advice to young Asian Americans, Native Hawaiians and Pacific Islanders about how to break through barriers.
Behind the barricades: How protesters spend their first days in a new encampment
Students in Montreal describe life in a newly erected encampment in Montreal as a whirlwind of preparations, from facing rain and a potential police crackdown to setting up a space for the exchange of ideas.
Security video caught admitted serial killer disposing of bodies in Winnipeg garbage bins
Security video caught admitted serial killer Jeremy Skibicki on multiple late-night outings, disposing of body parts in nearby garbage bins and dumpsters in the middle of the night.
Canucks' Soucy suspended 1 game, Zadorov fined $5,000 for post-game crosschecks on McDavid
A Vancouver Canucks defenceman has been suspended for a game and another was handed a hefty fine after a scrum broke out at the end of Game 3 against the Edmonton Oilers Sunday night.
'Judge Judy' Sheindlin sues for defamation over National Enquirer, InTouch Weekly stories
'Judge Judy' Sheindlin sued the parent company of the National Enquirer and InTouch Weekly on Monday for a story that she said falsely claimed that she was trying to help the Menendez brothers get a retrial after they were convicted of murdering their parents.